1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2015-2019 France Cancer Diagnostics Industry: Market Segmentation Analysis--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs

Complete report $6,700.  DataPack (test volumes, sales forecasts, supplier shares) $4,350.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.


“2015-2019 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the French cancer diagnostics market during the next five years.  The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.


Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.  During the next five years, the French cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field.  Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy.  The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.


French Market Overview


- Five-year test volume and sales projections.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers.


- Estimated universe of laboratories performing cancer diagnostic testing.


- Cancer statistics, etiology and recent developments in France.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Oncogenes

- Biochemical Markers

- Growth Factors

- Colony Stimulating Factors

- Hormones

- Immunohistochemical Stains

- Lymphokines


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test.


- Five-year test volume and sales forecasts

for major tumor markers by market segment, including:


     º  Hospitals

     º  Commercial/Private Laboratories



Instrumentation Review


- Analysis of major molecular diagnostic and immunodiagnostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies.


- Extensive listings of companies, universities

and research centers developing new cancer diagnostic tests

and detection technologies.


Competitive Strategies


- Strategic assessments of major suppliers

and start-up firms developing innovative cancer diagnostic

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- The companies analyzed in the report include:


   - Abbott

   - AdnaGen

   - Agilent Technologies

   - Applied Gene Technologies

   - Arca Biopharma

   - Beckman Coulter/Danaher

   - Becton Dickinson

   - Biomedical Diagnostics

   - bioMerieux

   - Bio-Rad

   - CellSearch

   - Cepheid

   - Correlogic Systems/Vermillion

   - Decode Genetics

   - Diadexus

   - Diagnocure

   - DiaSorin

   - Eiken Chemical

   - Elitech Group

   - Epigenomics

   - Enterix

   - Enzo Biochem

   - Exact Sciences

   - Fujirebio

   - Guided Therapeutics

   - Hologic/Gen-Probe

   - Kreatech/Leica

   - Kyowa Medex

   - Mackay Life Sciences

   - Myriad Genetics

   - OncoLab

   - Ortho-Clinical Diagnostics

   - Panacea Pharmaceuticals

   - Polartechnics

   - Polymedco

   - PreMD

   - Qiagen

   - Quest Diagnostics

   - Radient Pharmaceuticals

   - Roche

   - Scienion

   - Sequenom

   - Siemens Healthcare

   - Takara Bio

   - Targeted Diagnostics & Therapeutics

   - Thermo Fisher

   - Tosoh

   - Veridex

   - Wako Pure Chemicals

   - Wallac/PE

   - Zilla


Contains 585 pages and 85 tables

The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

“2015-2019 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs” is VPGMarketResearch’s new study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Table Of Contents

2015-2019 France Cancer Diagnostics Industry: Market Segmentation Analysis--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs
I. Introduction
II. Worldwide Market Overview
A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Worldwide Market and Technology Overview
A. Major Current and Emerging Cancer Diagnostic Tests
1. Biochemical Tumor Markers

2. Oncogenes

3. Polypeptide Growth Factors

4. Ectopic Hormones
5. Colony Stimulating Factors
6. Lymphokines
7. Immunohistochemical Stains
8. Emerging Tumor Markers
Table of Contents
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies

D. Personal Testing
VIII. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
- Volume Forecasts by Test and Market Segment
- Sales Forecasts by Test and Market Segment
- Major Supplier Sales and Market Shares
IX. Competitive Profiles
- Abbott
- AdnaGen
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
Table of Contents
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
- PreMD
- Qiagen/Ipsogen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics and Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

X. Appendix: Major Universities and Research
Centers Developing Cancer Diagnostic
Technologies and Applications





List of Tables

Cancer Diagnostic Classification
Major Companies Developing or Marketing
ACTH Tests
Major Companies Developing or Marketing
AFP Tests
Major Companies Developing or Marketing
Beta-2 Microglobulin Tests
Major Companies Developing or Marketing
CA 15-3/27.29 Tests
Major Companies Developing or Marketing
CA 19-9 Tests
Major Companies Developing or Marketing
CA 125 Tests
Major Companies Developing or Marketing
Calcitonin Tests
Major Companies Developing or Marketing
CEA Tests
Major Companies Developing or Marketing
Estrogen Receptor Tests
Major Companies Developing or Marketing
Progesterone Receptor Tests
Major Companies Developing or Marketing
Ferritin Tests
Major Companies Developing or Marketing
Gastrin Tests




List of Tables
Major Companies Developing or Marketing
HCG Tests

Major Companies Developing or Marketing
Insulin Tests

Major Companies Developing or Marketing
NSE Tests
Major Companies Developing or Marketing
Occult Blood Tests
Major Companies Developing or Marketing
PAP Smear/HPV Tests
Major Companies Developing or Marketing
PAP Tests
Major Companies Developing or Marketing
PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing
Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis




List of Tables
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Executive Summary Table: France, Total Cancer
Diagnostic Testing Volume and Sales Forecasts
by Market Segment
France, Estimated Cancer Death Rates
France, Laboratories Performing Cancer
Diagnostic Tests by Market Segment
France, Hospital Laboratories Performing
Cancer Diagnostic Tests by Bed Size
France, Commercial/Private Laboratories
Performing Cancer Diagnostic Test by Annual Test Volume
France, Total Cancer Diagnostic Test Volume
Forecasts by Market Segment
France, All Market Segments Major Cancer
Diagnostic Test Volume Forecasts by Test
France, Hospital Laboratories Major Cancer
Diagnostic Test Volume Forecasts by Test
France, Commercial/Private Laboratories
Marker Test Volume Forecasts
France, Total Cancer Diagnostic Sales Major Cancer Diagnostic
Forecasts by Market Segment
France, All Market Segments Major Cancer
Diagnostic Sales Forecasts by Test
France, Hospital Laboratories Major Cancer
Diagnostic Sales Forecasts by Test




List of Tables
France, Commercial/Private Laboratories Cancer
Diagnostic Market Forecasts by Test
France, ACTH Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, AFP Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, Beta-2 Microglobulin Test Volume and
Diagnostics Sales Forecasts by Market Segment

France, CA 15-3/27.29 Test Volume and
Diagnostics Sales Forecasts by Market Segment
France, CA 19-9 Test Volume and Diagnostics
Sales Forecasts by Market
France, CA-125 Test Volume and Diagnostics
Sales Forecasts by Market Segment
France, Calcitonin Test Volume and Diagnostics
Sales Forecasts by Market Segment
France, Cathepsin Test Volume and Diagnostics
Sales Forecasts by Market Segment
France, CEA Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, Colon-Specific Antigen Test Volume
And Diagnostics Sales Forecasts by Market Segment
France, Cytokeratins Test Volume and
Diagnostics Sales Forecasts by Market Segment





List of Tables
France, Estrogen Receptor Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Ferritin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Gastrin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, HCG Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, Insulin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Interferons Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Interleukins Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Lymphocyte Subtyping Test Volume
And Diagnostics Sales Forecasts by Market
Segment
France, NSE Test Volume and Diagnostics
Sales Forecasts by Market Segment
France, Nucleolar Test Volume and Diagnostics
Sales Forecasts by Market Segment
France, Occult Blood Test Volume and
Diagnostics Sales Forecasts by Market
Segment




List of Tables
France, Oncogenes Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Pancreatic Oncofetal Antigen
Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, PAP Smear Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Parathyroid Hormone Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Progesterone Receptor Test Volume
And Diagnostics Sales Forecasts by Market
Segment

France, PAP Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, PSA Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, S-100 Protein Test Volume and Sales
Diagnostics Sales Forecasts by Market
Segment
France, Serotonin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, Sialic Acid Test Volume and
Diagnostics Sales Forecasts by Market
Segment





List of Tables

France, Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, TDT Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, Thymidine Kinase Test Volume
And Diagnostics Sales Forecasts by
Market Segment
France, Thyroglobulin Test Volume and
Diagnostics Sales Forecasts by Market
Segment
France, TPA Test Volume and Diagnostics Sales
Forecasts by Market Segment
France, Total Cancer Diagnostics Sales
By Major Suppliers
France, AFP Testing Market Diagnostics
Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics
Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics
Sales by Major Supplier
France, CA 125 Testing Market Diagnostics
Sales by Major Supplier
France, CEA Testing Market Diagnostics
Sales by Major Supplier




List of Tables
France, NSE Testing Market Diagnostics
Sales by Major Supplier
France, PAP Testing Market Diagnostics
Sales by Major Supplier
France, PSA Testing Market Diagnostics
Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Cancer Diagnostics Market Future Horizons and Growth Strategies: Supplier Shares by Tumor Marker, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $19,700.  DataPack (test volumes, sales forecasts, supplier shares) $12,800.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.